Role of identified proteins in the proteome profiles of CDK4/6 inhibitor-resistant breast cancer cell lines-Reference-Cited by-同舟云学术

Role of identified proteins in the proteome profiles of CDK4/6 inhibitor-resistant breast cancer cell lines

Published:2023 Issue:5 Volume:19 Page:404-417
ISSN:2515-4184
Container-title:Molecular Omics
language:en
Short-container-title:Mol. Omics

Author:

Kumar Binayak¹,Prasad Peeyush²,Singh Ragini¹,Sahu Ram Krishna¹,Singh Ashutosh³^ORCID,Magani Srikrishna Jayadev³,Hedau Suresh¹^ORCID

Affiliation:

1. Division of Molecular Oncology, ICMR-National Institute of Cancer Prevention and Research, I–7, Sector-39, Noida, Uttar Pradesh, 201301, India

2. Department of Research, Sir Ganga Ram Hospital, 110060, New Delhi, India

3. Department of Life Sciences, Shiv Nadar University, NH-91, Tahsil-Dadri, Distt-Gautam Budhaa Nagar, Uttar Pradesh, 201314, India

Abstract

Abemaciclib (Ab) and palbociclib (Pb) are CDK4/6 inhibitors used to cure advanced breast cancer (BC).

Funder

Indian Council of Medical Research

Publisher

Royal Society of Chemistry (RSC)

Subject

Genetics,Molecular Biology,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/MO/D2MO00285J

Reference54 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer Incidence in Five Continents , ed. M. P. Curado , B. Edwards , H. R. Shin , H. Storm , J. Ferlay , M. Heanue , P. Boyle , IARC Scientific Publications No. 160 , Lyon, IARC , 2007 , vol. IX

3. D.Forman , F.Bray , D. H.Brewster , C.GombeMbalawa , B.Kohler , M.Piñeros , E.Steliarova- Foucher , R.Swaminathan and J.Ferlayeds , Cancer Incidence in Five Continents , Lyon, IARC , 2013 , vol. X, electronic version

4. Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions;International Journal of Molecular Sciences;2023-07-22